Tradestie Institutional Equity Comparison Engine

DSAC vs BIOT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DSAC Overall Edge

DSAC Captures Institutional Edge (1โ€“0 Pillars ยท 3โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DSAC (DSAC) driven by superior Momentum & Technical. Fundamentally, DSAC trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus BIOT at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, DSAC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BIOT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
DSAC N/M vs BIOT N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner DSAC
1Y +1.8% vs -98.8% ยท 52W Pos 50% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
DSAC US Equity
DSAC
Institutional Equity
$10.18
+0.39% 1D
Market Cap N/A
1M Return +0.3%
1Y Return +1.8%
Forward P/E N/M
Unified AI Score
57.0 / 100 HOLD
Tech 50.0 Fund 53.0 Flow 50.0 Mom 60.0
BIOT US Equity
BIOT
Institutional Equity
$0.19
-1.1% 1D
Market Cap N/A
1M Return -17.65%
1Y Return -98.79%
Forward P/E N/M
Unified AI Score
52.7 / 100 HOLD
Tech 52.0 Fund 69.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DSAC +1.8% BIOT -98.79% Spread: +98.99 pp (DSAC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DSAC TTM Op. Margin: N/A BIOT TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DSAC vs BIOT. Trailing 12-month operating profitability (DSAC N/A vs BIOT N/A) and valuation multiples (DSAC N/M vs BIOT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DSAC (3) vs BIOT (0)
Institutional Metric DSAC BIOT Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 50% ($10โ€“$10) 0% ($0โ€“$50) Stronger Trend DSAC
Beta / 30D Volatility Risk Regime -0.01ฮฒ ยท 2% Vol 2.81ฮฒ ยท 101% Vol Lower Realized Risk DSAC
Unified Institutional Score Composite Signal 57.0 / 100 (HOLD) 52.7 / 100 (HOLD) Higher Composite DSAC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DSAC vs BIOT Buy Guide
DSAC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DSAC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BIOT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BIOT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DSAC nor BIOT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.